Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
about
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskThe role of the lymphatic system in cholesterol transportMolecular mechanisms of cellular cholesterol effluxWill Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and AtherosclerosisResidual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density LipoproteinHigh-Density Lipoprotein Processing and Premature Cardiovascular DiseaseNo effect of acute exposure to coarse particulate matter air pollution in a rural location on high-density lipoprotein functionEpidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetesSite-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.High-density lipoprotein metabolism, composition, function, and deficiency.Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.Cholesterol and lipoprotein metabolism: Early Career Committee contributionAnti-psoriatic therapy recovers high-density lipoprotein composition and function.Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.Dysfunctional high-density lipoproteins in children with chronic kidney diseaseHDL cholesterol efflux capacity and incident cardiovascular events.Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of functionA novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacityHigh-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis.Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol levelAssociation of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control studyNew Insights into the High-Density Lipoprotein DilemmaHDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.The effects of apolipoprotein B depletion on HDL subspecies composition and functionA Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.Regulation of signal transduction by HDL.
P2860
Q26775420-300FE2ED-2314-4708-8BF3-0EF6233C8B4AQ26782973-BD94A4DC-02DC-4A43-BE57-38029A2FD565Q27021139-1AE638D9-5721-480E-AC3F-12B7CBDE812EQ28080768-4F064D04-168E-4731-9B78-CA2A845E3B63Q28083058-FDD4F888-2085-46DF-9DF4-AB39F79E0DCCQ28083619-1E953E40-7487-4851-8B7F-441752041D8DQ28085143-7A82310B-B40E-49F5-AD58-D3F19763E7F7Q28394963-CC94960C-A219-4424-B322-490EADC2099BQ30251632-B5E63AAF-7108-41F6-9955-47534CD43AF7Q30251918-FC762C2B-39FE-40F2-8AE0-5775B1C2F579Q33582205-522797CA-0A84-4488-A817-BFCF39AB3DE5Q33675617-3473A514-D966-454E-AC9B-23BA9BFED2D1Q33848028-9F2F05BC-5782-4C20-8AFC-FEEEEA6A3975Q33940012-923561CF-9D90-4D5E-B882-FCDF4A279A55Q34076117-D7D3E381-5D7F-4D18-83A0-4893497AD528Q34081210-0D02C0A2-2B19-4175-B544-A623CDB1EE26Q34259215-FA061D0D-FFB5-430C-A84B-F409EC656F52Q34565234-2F5DC218-6207-40DE-AB67-3EDED71A0F27Q34627415-EC2A3755-8505-47FF-9BD3-DCE3E59EC70CQ34779002-0FADA2FD-C819-4395-ABC3-4524F81F763CQ35021594-43431555-BF64-4A0A-AE02-BE5CE6ABFD4FQ35036648-165FEEC4-AB3E-4210-88F5-D8DFB5FB70CFQ35120931-50FCFDC3-DDDE-4CA0-84FD-9FB61E43DE9AQ35120941-30C25AC7-2C02-41F9-B8F4-6166D87E93F4Q35686360-B1EA12DD-5E37-4A73-A255-4F214ECFFA35Q35802117-B73F8DAB-DC66-4A54-AAC8-4B920F22A435Q35886286-63A0E6BF-555A-4043-BDC8-340B994C6703Q36030580-63D2CAC1-56D9-49CA-BD83-38B568BB6781Q36093194-7B6C4900-94EA-4DC2-8002-0B85986E18E3Q36157875-7B335C8D-41AD-4B40-A1A0-A33F40383571Q36282932-73632804-2ADF-454A-A3A9-AA1AEAFF6084Q36287533-28E65A14-1BFD-478F-A697-6F2C50043AAFQ36450075-4817A855-485E-4683-BDF1-1AE8675D5C99Q36514875-A1C00963-F62F-4186-8E45-4874512EEC94Q36720650-4041A614-874B-41DC-A5B0-1824D35EFE59Q36731786-A2D59231-8B1E-4AE1-8EE1-39F1736F5FE6Q36744820-24993657-83C7-442B-852C-295B25E3D30DQ36782847-10705ACF-0C89-4F1C-BB7C-BB3BAEF38D9AQ36988873-1F6907AE-FBFC-4BB3-B8DF-916B689A613EQ37076473-A89D7F6A-3CE9-43C8-AF53-2C08D86040DC
P2860
Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Paradoxical association of enh ...... incident cardiovascular risks.
@en
Paradoxical association of enh ...... incident cardiovascular risks.
@nl
type
label
Paradoxical association of enh ...... incident cardiovascular risks.
@en
Paradoxical association of enh ...... incident cardiovascular risks.
@nl
prefLabel
Paradoxical association of enh ...... incident cardiovascular risks.
@en
Paradoxical association of enh ...... incident cardiovascular risks.
@nl
P2093
P2860
P1476
Paradoxical association of enh ...... incident cardiovascular risks.
@en
P2093
David Schmitt
Joseph A Didonato
Marian K Mosior
Stanley L Hazen
Vivian Gao
Wai Hong Wilson Tang
William Matter
Xin-Min Li
Ying Huang
P2860
P304
P356
10.1161/ATVBAHA.113.301373
P407
P577
2013-03-21T00:00:00Z